Outcomes of Patients After Attempted MRSA Decolonization
Investigating the Effects of Decolonization on Patient Health Outcomes
Brief description of study.
Does decolonization benefit the individual patient by reducing the subsequent risk of death or readmission or serious MRSA infection?
Detailed description of study
Does decolonization benefit the individual patient by reducing the subsequent risk of death or readmission or serious MRSA infection?
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: MRSA
-
Age: 100 years or below
-
Gender: All
This study investigates whether decolonization can reduce the risk of death, readmission, or serious MRSA infections in patients. MRSA, or Methicillin-resistant Staphylococcus aureus, is a type of bacteria that is resistant to many antibiotics, making it difficult to treat. Decolonization involves removing bacteria from the body to prevent infections.
Participants will undergo procedures to assess the effectiveness of decolonization in preventing serious health outcomes related to MRSA. The study will compare different approaches to determine the best method for reducing risks associated with MRSA infections.
- Who can participate: Participants aged 18 and older who have a history of MRSA infection or are at high risk for MRSA may be eligible. Key eligibility factors include previous MRSA colonization or infection and no known allergies to the investigational treatment.
- Study details: Participants will be involved in procedures to evaluate the impact of decolonization on health outcomes related to MRSA. The study will include a placebo group, which will receive an inactive substance that looks like the investigational treatment but does not contain any medicine.
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
Please choose between Voice or SMS based delivery of verification code
or